---
id: 062
title: Azole Antifungals Spectrum Comparison
category: antimicrobials
subcategory: azoles
tags: [azoles, fluconazole, voriconazole, posaconazole, isavuconazole, spectrum]
difficulty: medium
---

## Question

What is the spectrum of activity for the four major azoles? Use the **"Flu-Vori-Posa-Isavu SPECTRUM"** mnemonic.

## Answer

### **"Flu-Vori-Posa-Isavu SPECTRUM" Mnemonic:**

**FLU** (Fluconazole = Narrow):
- **F**ungicidal for *Candida* (except *C. krusei*, variable *C. glabrata*)
- **L**imited to yeasts only
- **U**seless for molds (no *Aspergillus*)

**VORI** (Voriconazole = Broad for molds):
- **V**ery broad: yeasts + molds
- **O**ptimal for *Aspergillus* (1st-line)
- **R**esistant: Mucorales (NO mucor coverage)
- **I**nvasive fungal infections (1st-line)

**POSA** (Posaconazole = Broadest):
- **P**rophylaxis for high-risk patients
- **O**nly azole with mucor activity
- **S**alting molds: *Aspergillus*, Mucorales, *Fusarium*
- **A**ll endemic fungi covered

**ISAVU** (Isavuconazole = Vori alternative):
- **I**nvasive aspergillosis (non-inferior to vori)
- **S**alvage for mucormycosis
- **A**lternative to voriconazole (fewer side effects)
- **V**ery long half-life (130 hrs)
- **U**seful broad-spectrum option

### **Spectrum Comparison Table:**

| Organism | Fluconazole | Voriconazole | Posaconazole | Isavuconazole |
|----------|-------------|--------------|--------------|---------------|
| ***Candida albicans*** | ✅ 1st-line | ✅ Yes | ✅ Yes | ✅ Yes |
| ***C. glabrata*** | ⚠️ Variable (dose-dependent) | ✅ Yes | ✅ Yes | ✅ Yes |
| ***C. krusei*** | ❌ Resistant | ✅ Yes | ✅ Yes | ✅ Yes |
| ***C. auris*** | ❌ Often resistant | ⚠️ Variable | ⚠️ Variable | ⚠️ Variable |
| ***Cryptococcus*** | ✅ 1st-line | ✅ Yes | ✅ Yes | ✅ Yes |
| ***Aspergillus*** | ❌ NO | ✅ **1st-line** | ✅ Yes | ✅ **1st-line** |
| **Mucorales** (mucor) | ❌ NO | ❌ **NO** | ✅ **YES** | ✅ Yes (salvage) |
| ***Fusarium*** | ❌ NO | ✅ Yes | ✅ Yes | ✅ Yes |
| ***Scedosporium*** | ❌ NO | ✅ Yes | ✅ Yes | ✅ Yes |
| **Endemic fungi** | ⚠️ Variable | ✅ Yes | ✅ Yes | ✅ Yes |

## Key Points

### **Clinical Indications by Agent:**

**Fluconazole:**
- Candidemia (non-*krusei*, non-resistant *glabrata*)
- Cryptococcal meningitis (induction + maintenance)
- Oropharyngeal/esophageal candidiasis
- Candida prophylaxis (transplant, ICU)

**Voriconazole:**
- **Invasive aspergillosis (1st-line)**
- Invasive *Fusarium*, *Scedosporium*
- Salvage therapy for endemic fungi
- Refractory *Candida* infections

**Posaconazole:**
- **Prophylaxis** (AML/MDS, GVHD, neutropenic)
- **Mucormycosis** (salvage or primary if ampho B contraindicated)
- Invasive aspergillosis (alternative)
- Refractory invasive fungal infections

**Isavuconazole:**
- Invasive aspergillosis (non-inferior to vori)
- **Mucormycosis** (salvage therapy)
- Alternative to voriconazole (better tolerated)

### **Pharmacokinetic Highlights:**

| Agent | Half-life | Bioavailability | TDM Needed? |
|-------|-----------|-----------------|-------------|
| **Fluconazole** | 30 hrs | 90% (PO) | Rarely |
| **Voriconazole** | 6 hrs | 96% (PO) | **YES** (target 1-5 µg/mL) |
| **Posaconazole** | 27-35 hrs | Variable (food-dependent) | **YES** (target >1 µg/mL) |
| **Isavuconazole** | **130 hrs** | 98% (PO) | Optional |

### **Key Differences:**

**Mucor Coverage:**
- **Posaconazole**: 1st-line azole for mucor
- **Isavuconazole**: Salvage for mucor
- **Voriconazole/Fluconazole**: ❌ NO mucor coverage

**Invasive Aspergillosis:**
- **Voriconazole**: 1st-line (IDSA guideline)
- **Isavuconazole**: Non-inferior alternative (better tolerated)
- **Posaconazole**: Alternative
- **Fluconazole**: ❌ NO activity

## Sources

- [StatPearls NBK551581: Antifungal Ergosterol Synthesis Inhibitors]
- [PMC7712939: Isavuconazole Mechanism and Clinical Efficacy]
- [Oxford Academic 2019: Broad Spectrum Triazoles for Invasive Mould Infections]

## Media

N/A
